This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fisher, N. D. L. Articles by Williams, G. H. Search for Related Content PubMed PubMed Citation Articles by Fisher, N. D. L. Articles by Williams, G. H. Related Collections Nutrition Other hypertension Genetics of cardiovascular disease

(Hypertension. 1999;34:388-394.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Altered Adrenal Sensitivity to Angiotensin II in Low-Renin Essential Hypertension

Naomi D. L. Fisher; Shelley Hurwitz; Claudio Ferri; Xavier Jeunemaitre; Norman K. Hollenberg; Gordon H. Williams

From the Departments of Medicine and Radiology, Harvard Medical School and Brigham and Women's Hospital, Boston, Mass; Università La Sapienza, Rome, Italy (C.F.); and Centre d'Investigation Clinique, Service d'Hypertension Arterielle, Hôpital Broussais, Paris, France (X.J.).

Abstract—Low-renin essential hypertension (LREH) describes a widely recognized classification validated by clinical features, including salt-sensitive blood pressure and diuretic responsiveness. Classic physiological teaching has cited normal plasma aldosterone concentration despite suppressed renin as evidence for adrenal supersensitivity to angiotensin II (Ang II). We studied 94 patients with LREH, 242 normal-renin hypertensives, and 135 normal subjects as controls. Low-renin hypertensives did not differ significantly from the other groups in either basal or Ang II–stimulated aldosterone concentrations on a high-sodium diet. Stimulated with a low-sodium diet, LREH patients demonstrated the smallest rise in basal aldosterone secretion. Ang II responsiveness was also subnormal: the rise in aldosterone after Ang II infusion in LREH (613±39 pmol/L), although greater than in nonmodulators (180±17 pmol/L; P=0.001), was less than either the patients with intact modulation (940±53 pmol/L; P=0.001) or normotensives (804±50 pmol/L; P<0.05). Blacks with LREH demonstrated an even lower response than low-renin whites ((388±50 versus 610±47 pmol/L; P=0.0001). In contrast, the rise in systolic blood pressure with Ang II infusion on a low-salt diet was greatest among LREH patients (P=0.001). Patients with LREH and nonmodulators were equally salt-sensitive. These results indicate that the adrenal response in LREH is normal on a high-salt diet but becomes progressively more abnormal as sodium control mechanisms are stressed. The factors that mediate enhanced adrenal response to Ang II with sodium restriction may be defective, suggesting the existence of alternative physiological mechanisms for sodium homeostasis in the low-renin state.

Key Words: renin • sodium • angiotensin II • aldosterone • posture • blacks

This article has been cited by other articles:

				L. Pojoga, N. S. Kolatkar, J. S. Williams, T. S. Perlstein, X. Jeunemaitre, N. J. Brown, P. N. Hopkins, B. A. Raby, and G. H. Williams {beta}-2 Adrenergic Receptor Diplotype Defines a Subset of Salt-Sensitive Hypertension Hypertension, November 1, 2006; 48(5): 892 - 900. [Abstract] [Full Text] [PDF]

				E. D. Szmuilowicz, G. K. Adler, J. S. Williams, D. E. Green, T. M. Yao, P. N. Hopkins, and E. W. Seely Relationship between Aldosterone and Progesterone in the Human Menstrual Cycle J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3981 - 3987. [Abstract] [Full Text] [PDF]

				E. M. Freel and J. M.C. Connell Mechanisms of Hypertension: The Expanding Role of Aldosterone J. Am. Soc. Nephrol., August 1, 2004; 15(8): 1993 - 2001. [Abstract] [Full Text] [PDF]

				K. Stolarz, J. A. Staessen, K. Kawecka-Jaszcz, E. Brand, G. Bianchi, T. Kuznetsova, V. Tikhonoff, L. Thijs, T. Reineke, S. Babeanu, et al. Genetic Variation in CYP11B2 and AT1R Influences Heart Rate Variability Conditional on Sodium Excretion Hypertension, August 1, 2004; 44(2): 156 - 162. [Abstract] [Full Text] [PDF]

				R. Slim, F. Torremocha, T. Moreau, A. Pizard, S. C. Hunt, A. Vuagnat, G. H. Williams, F. Gauthier, X. Jeunemaitre, and F. Alhenc-Gelas Loss-of-Function Polymorphism of the Human Kallikrein Gene with Reduced Urinary Kallikrein Activity J. Am. Soc. Nephrol., April 1, 2002; 13(4): 968 - 976. [Abstract] [Full Text] [PDF]

				N. D.L. Fisher, S. Hurwitz, X. Jeunemaitre, P. N. Hopkins, N. K. Hollenberg, and G. H. Williams Familial Aggregation of Low-Renin Hypertension Hypertension, April 1, 2002; 39(4): 914 - 918. [Abstract] [Full Text] [PDF]

				S.-J. Shi, H. T. Nguyen, G. D. Sharma, L. G. Navar, and K. N. Pandey Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels Am J Physiol Renal Physiol, October 1, 2001; 281(4): F665 - F673. [Abstract] [Full Text] [PDF]

				R Foo, K M O'Shaughnessy, and M J Brown Hyperaldosteronism: recent concepts, diagnosis, and management Postgrad. Med. J., October 1, 2001; 77(912): 639 - 644. [Full Text] [PDF]

				A. H. El-Gharbawy, V. S. Nadig, J. M. Kotchen, C. E. Grim, K. B. Sagar, M. Kaldunski, P. Hamet, Z. Pausova, D. Gaudet, F. Gossard, et al. Arterial Pressure, Left Ventricular Mass, and Aldosterone in Essential Hypertension Hypertension, March 1, 2001; 37(3): 845 - 850. [Abstract] [Full Text] [PDF]

				M. Giacche, A. Vuagnat, S. C. Hunt, P. N. Hopkins, N. D. L. Fisher, M. Azizi, P. Corvol, G. H. Williams, and X. Jeunemaitre Aldosterone Stimulation by Angiotensin II : Influence of Gender, Plasma Renin, and Familial Resemblance Hypertension, March 1, 2000; 35(3): 710 - 716. [Abstract] [Full Text] [PDF]

				D. G. Warnock Low-Renin and Nonmodulating Essential Hypertension Hypertension, September 1, 1999; 34(3): 395 - 397. [Full Text] [PDF]